Mixed news on medicines scheduling

Regulators confirm that no change is to be made to astrodrimer sodium gel scheduling despite opposition from leading pharmacy groups. However another change is confirmed The Therapeutic Goods Administration's Advisory Committee on Medicines Scheduling (ACMS) has confirmed its previous decision to reject the rescheduling of astrodrimer sodium vaginal gels for the treatment, relief and prevention